The European Commission’s proposal to reform the oversight of medical devices and diagnostics does not envision a pre-market approval agency akin to FDA as some had feared, but it would clearly increase the role of government in the process and slow launches for some products.
The Commission, which serves as the executive branch of the European Union government, issued proposed legislation Sept. 26 to make large-scale revisions to the highly decentralized regulatory system for devices...